Can SGLT2 Inhibitors Limit Acute Kidney Injury in Type 2 Diabetes? Can SGLT2 Inhibitors Limit Acute Kidney Injury in Type 2 Diabetes?

Contrary to the concerns that SGLT2 inhibitors might increase the risk of acute kidney injury when they were first introduced, new data support other findings that this complication is likely not an issue.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news